Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - CASH FROM OPERATIONS
Cash from Operations REGN - Regeneron Pharmaceuticals, Inc.
4.59 B
LAST VALUE
-19.45%
2 YEAR CAGR
15.92%
5 YEAR CAGR
22.81%
10 YEAR CAGR